AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Revenue

In the fiscal year ending March 31, 2026, AstraZeneca Pharma India had annual revenue of 22.76B INR with 32.59% growth. AstraZeneca Pharma India had revenue of 5.79B in the quarter ending March 31, 2026, with 20.42% growth.

• Revenue: 22.76B
• Revenue Growth: +32.59%
• P/S Ratio: 8.86
• Revenue / Employee: 37.93M
• Employees: 600
• Market Cap: 201.59B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	22.76B	5.59B	32.59%
Mar 31, 2025	17.16B	4.21B	32.48%
Mar 31, 2024	12.96B	2.93B	29.17%
Mar 31, 2023	10.03B	1.97B	24.50%
Mar 31, 2022	8.06B	-79.60M	-0.98%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error